Organon & Co. Common Stock (OGN)
R&D Expenses
$90.00M
Quarterly · Period ending: · USD
OGN R&D Expenses
Latest reported$90.00Mperiod ending
Latest reported$90.00Mperiod ending
OGN Quarterly R&D Expenses ($45.00M → $90.00M)
Quarterly R&D Expenses
High-resolution chart · PNG
OGN r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 90,000,000 | |
| 93,000,000 | |
| 91,000,000 | |
| 84,000,000 | |
| 95,000,000 | |
| 96,000,000 | |
| 130,000,000 | |
| 111,000,000 | |
| 116,000,000 | |
| 112,000,000 | |
| 134,000,000 | |
| 137,000,000 | |
| 128,000,000 | |
| 129,000,000 | |
| 142,000,000 | |
| 127,000,000 | |
| 106,000,000 | |
| 96,000,000 | |
| 110,000,000 | |
| 111,000,000 | |
| 76,000,000 | |
| 67,000,000 | |
| 60,000,000 | |
| 54,000,000 | |
| 51,000,000 | |
| 45,000,000 |